ASAPS formed an ad hoc committee to further investigate the pros and cons of mesotherapy, he says. "We don't know whether it works or not because it is used by a lot of people who inject all kinds of chemicals into the skin," Fodor explains. "Our committee looked at the literature and we found no uniformity to what is being used, how much is being injected, and where it is being injected, so we could not draw any conclusions," he says. That's why ASAPS is conducting a clinical trial at five centers to definitively answer questions about mesotherapy. "We will do some studies with an exact and rigid protocol so we can compare apples to apples, not apples to oranges," he says.
The best way to determine whether you’re fit for undergoing body sculpting without surgery is to consult the physician directly. There are two types of fat present in a human body. The first type is called visceral fat. This fat is present deep inside the muscle tissues and are not soft or pinchable. The other type is called subcutaneous fat. This kind of fat is present above the muscle and are really soft and pinchable. Subcutaneous fat can be easily removed using non-invasive techniques like laser contouring. However, if you are someone who carries a lot of visceral fat, you will need to take the long road and exercise to get a perfectly toned body.
As the name suggests, the CoolSculpting procedure can be a little chilly. Controlled cooling is delivered via an applicator to freeze the targeted fat. Though you may feel intense cold initially, this feeling usually subsides within 5 to 10 minutes as the area numbs. Because most applicators use a vacuum to draw fatty tissue into the applicator cup, you may also feel some pulling, tugging, and/or mild pinching.
The “AXA PPP Group” for this purpose is AXA PPP healthcare Group Limited, its holding company and all subsidiaries of its holding company including (but not limited to) AXA PPP healthcare Limited, AXA ICAS Limited, AXA ICAS Occupational Health Services Limited, Health on Line Company UK Limited and AXA PPP healthcare Administration Services Limited.
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.
1 July 2015: The CMA is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.